Want to join the conversation?
Biopharmaceutical company $REGN posted almost flat 2Q16 results. $REGN said net income rose 0.51% to $196MM, or $1.69 per share from $195MM, or $1.69 per share a year ago. Total revenues rose 21.42% to $1.21Bil versus a year ago, helped by inclusion of Sanofi and Bayer collaboration revenues. Excluding items $REGN earned $2.82 per share.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.